We are live on ! Find out more
TECH icon

Bio-Techne

341 hedge funds and large institutions have $7.05B invested in Bio-Techne in 2019 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 105 increasing their positions, 127 reducing their positions, and 60 closing their positions.

New
Increased
Maintained
Reduced
Closed

4.04% more ownership

Funds ownership: 376.23%380.27% (+4%)

6% less capital invested

Capital invested by funds: $7.5B → $7.05B (-$455M)

8% less funds holding

Funds holding: 369341 (-28)

17% less repeat investments, than reductions

Existing positions increased: 105 | Existing positions reduced: 127

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

47% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 60

80% less call options, than puts

Call options by funds: $372K | Put options by funds: $1.88M

Holders
341
Holders Change
-28
Holders Change %
-7.59%
% of All Funds
7.46%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
32
Increased
105
Reduced
127
Closed
60
Calls
$372K
Puts
$1.88M
Net Calls
-$1.51M
Net Calls Change
+$2.14M

TECH Hedge Fund Activity: Q3 2019 in Review

341 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q3 2019, worth a combined $7.05B — down 6.1% from $7.5B a quarter earlier.

Sellers outnumbered buyers: 60 funds closed out of TECH and 32 opened new positions — a net loss of 28 holders — while 127 trimmed existing stakes and 105 added.

The largest buyer was DF Dent & Co, adding an estimated $30.6M. The largest seller was First Trust Advisors, cutting an estimated $44.1M.

  • 341 institutional investors held Bio-Techne (TECH) as of Q3 2019, down from 369 in Q2 2019.
  • Funds reported $7.05B of Bio-Techne stock for Q3 2019, down 6.1% quarter-over-quarter.
  • 32 funds opened new Bio-Techne positions in Q3 2019 and 60 closed out, a net change of -28 holders.
  • The largest Bio-Techne buyer in Q3 2019 was DF Dent & Co, an estimated $30.6M added.
  • The largest Bio-Techne seller in Q3 2019 was First Trust Advisors, an estimated $44.1M sold.

Based on aggregated 13F filings for Q3 2019.